September 2024

SAN FRANCISCO and SUZHOU, China, Sept. 11, 2024 /PRNewswire/ — Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metaboli

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: